Zacks Investment Research
10 Nov 2025, 17:25 UTC · 51w ago
Verdict
Headline takes no side. We score NVO −1.00 — strongly bearish.
−1.00strongly bearish
More negative than 99% of ticker scores this week
Which stocks this story touches
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 3 movers · tap to explore
More positive than 98% of ticker scores this week
Reported strong earnings and sales and raised its EPS outlook for 2025.
More positive than 78% of ticker scores this week
Highlighted as poised to deliver an earnings beat in upcoming results.
More positive than 78% of ticker scores this week
Highlighted as poised to deliver an earnings beat in upcoming results.
More positive than 78% of ticker scores this week
Highlighted as poised to deliver an earnings beat in upcoming results.
More positive than 78% of ticker scores this week
Highlighted as poised to deliver an earnings beat in upcoming results.
More positive than 64% of ticker scores this week
Mentioned as an arch-rival causing intensifying competition and pressure for Novo Nordisk.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
MarketBeat
1h ago
−12.0%
Price agrees with the score
$40.19 vs $45.68 close before publication (Nov 7) · not market-adjusted
NVO chart →
